Skip to main content
. 2021 May 29;22:360–376. doi: 10.1016/j.omtm.2021.05.010

Table 1.

Distribution of identified somatic variations

Tissue source Patient ID All somatic variants
Somatic driver variants
UTR3 UTR5 Exonic UTR3 UTR5 Exonic
Tumor tissue P1 2,217 365 13 103 18 2
P2 2,488 426 13 127 23 0
P4 2,238 439 7 95 20 0
P5 2,589 453 13 130 22 0
P6 2,141 419 6 88 17 0
Urine exosomes P1 3,442 470 25 188 28 1
P2 2,189 345 25 105 22 2
P4 287 75 93 7 4 3
P5 1,215 192 23 85 4 3
P6 1,229 172 30 55 11 2
Serum exosomes P1 118 44 62 5 5 1
P2 1,047 175 62 72 16 1
P4 460 141 68 19 5 4
P5 766 142 8 57 11 1
P6 150 48 52 6 3 2

In the discovery-based approach, somatic variants in all samples were identified by filtering against all variants found in the normal tissue (PBMC) sequence, followed by using the minor allelic frequency (MAF) test. P1–P6, patients 1–6.